Merck Antiviral Pill
Merck on Friday announced that its new pill to treat Covid-19 reduced the risk of hospitalization and death by about 50 percent. In the phase three trial it was discovered that the pill works by inhibiting the replication of the virus inside the body. Pin On Belize Recipes Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for COVID-19. Merck antiviral pill . Merck announced on Wednesday a supply and purchase agreement that will provide Singapore with access to its experimental oral COVID-19 antiviral drug the latest Asian country to try to snap up supplies. 1 2021 256 PM UTC. Study results of 775 patients showed that no cases passed away after receiving the drug. 1 2021 0236 Oct. Merck says its antiviral pill reduces COVID-19 hospitalizations and deaths Oct. Antiviral treatments now in use such as remdesivir are administered intravenously. After tests that have yet to face peer review US...